{"id":12163,"date":"2024-08-28T13:48:50","date_gmt":"2024-08-28T10:48:50","guid":{"rendered":"https:\/\/tlab.com.tr\/?p=12163"},"modified":"2025-03-26T11:58:12","modified_gmt":"2025-03-26T08:58:12","slug":"comparison-of-platelet-rich-plasma-efficacy-with-and-without-photoactivation-in-melasma-a-randomized-double-blind-study","status":"publish","type":"post","link":"https:\/\/tlab.com.tr\/en\/comparison-of-platelet-rich-plasma-efficacy-with-and-without-photoactivation-in-melasma-a-randomized-double-blind-study\/","title":{"rendered":"Comparison of platelet-rich plasma efficacy with and without photoactivation in melasma: A randomized double-blind study"},"content":{"rendered":"<p>Abstract<\/p>\n\n\n\n<p><strong>Background:&nbsp;<\/strong>Photoactivation has been suggested to enhance the efficacy of platelet-rich plasma (PRP) in conditions other than dermatological diseases.<\/p>\n\n\n\n<p><strong>Aims:&nbsp;<\/strong>To evaluate the efficacy of photoactivated PRP (P-PRP) treatment for melasma by comparing it with non-photoactivated, classical PRP (C-PRP).<\/p>\n\n\n\n<p><strong>Methods:&nbsp;<\/strong>The study consisted of 38 female patients diagnosed with melasma between April 2022 and May 2023. The patients were randomized into the P-PRP and C-PRP groups. Three sessions of P-PRP or C-PRP were applied to the patients at 2-week intervals. The Melasma Area and Severity Index (MASI) and Melasma Quality of Life Index (MELASQoL) scores were compared before and 2 weeks after treatment.<\/p>\n\n\n\n<p><strong>Results:&nbsp;<\/strong>The median age was 38 years, and the median disease duration was 60 months. Clinically, 94.7% of the cases were centrofacial and 5.3% were malar. According to Wood&#8217;s lamp examination, 55.3% of the cases were epidermal, 13.2% were dermal, and 31.6% were mixed-type. The median pre- and post-treatment scores were 14.5 and 9, respectively, for MASI and 36.5 and 17, respectively, for MELASQoL. The post-treatment MASI and MELASQoL scores of both groups significantly decreased (p &lt; 0.001 for both). However, the intergroup difference was not significant. When all patients were evaluated together a moderate, positive, and significant relationship was detected between PRP and the pre- and post-treatment MASI and MELASQoL scores (r = 0.494 and p = 0.002). No side effects associated with PRP were observed.<\/p>\n\n\n\n<p><strong>Conclusion:\u00a0<\/strong>PRP is an effective and safe treatment method for melasma. Further studies are needed to evaluate the contribution of photoactivation to PRP treatment in melasma.<\/p>\n\n\n\n<div class=\"wp-block-buttons is-content-justification-center is-layout-flex wp-container-core-buttons-is-layout-16018d1d wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link has-text-align-center wp-element-button\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39175423\/\" target=\"_blank\" rel=\"noopener\">Click here to read<\/a><\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Abstract Background:&nbsp;Photoactivation has been suggested to enhance the efficacy of platelet-rich plasma (PRP) in conditions other than dermatological diseases. Aims:&nbsp;To evaluate the efficacy of photoactivated PRP (P-PRP) treatment for melasma by comparing it with non-photoactivated, classical PRP (C-PRP). Methods:&nbsp;The study consisted of 38 female patients diagnosed with melasma between April 2022 and May 2023. The patients were randomized into the P-PRP and C-PRP groups. Three sessions of P-PRP or C-PRP were applied to the patients at 2-week intervals. The Melasma Area and Severity Index (MASI) and Melasma Quality of Life Index (MELASQoL) scores were compared before and 2 weeks after treatment. Results:&nbsp;The median age was 38 years, and the median disease duration was 60 months. Clinically, 94.7% of the cases were centrofacial and 5.3% were malar. According to Wood&#8217;s lamp examination, 55.3% of the cases were epidermal, 13.2% were dermal, and 31.6% were mixed-type. The median pre- and post-treatment scores were 14.5 and 9, respectively, for MASI and 36.5 and 17, respectively, for MELASQoL. The post-treatment MASI and MELASQoL scores of both groups significantly decreased (p &lt; 0.001 for both). However, the intergroup difference was not significant. When all patients were evaluated together a moderate, positive, and significant relationship was detected between PRP and the pre- and post-treatment MASI and MELASQoL scores (r = 0.494 and p = 0.002). No side effects associated with PRP were observed. Conclusion:\u00a0PRP is an effective and safe treatment method for melasma. Further studies are needed to evaluate the contribution of photoactivation to PRP treatment in melasma.<\/p>","protected":false},"author":4,"featured_media":12165,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"categories":[58,108,83,98],"tags":[],"class_list":["post-12163","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-akademik-makaleler","category-dermatology_","category-dermatology","category-plastic-reconstructive-and-aesthetic-surgery"],"views":111,"_links":{"self":[{"href":"https:\/\/tlab.com.tr\/en\/wp-json\/wp\/v2\/posts\/12163","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tlab.com.tr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tlab.com.tr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tlab.com.tr\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/tlab.com.tr\/en\/wp-json\/wp\/v2\/comments?post=12163"}],"version-history":[{"count":3,"href":"https:\/\/tlab.com.tr\/en\/wp-json\/wp\/v2\/posts\/12163\/revisions"}],"predecessor-version":[{"id":12560,"href":"https:\/\/tlab.com.tr\/en\/wp-json\/wp\/v2\/posts\/12163\/revisions\/12560"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tlab.com.tr\/en\/wp-json\/wp\/v2\/media\/12165"}],"wp:attachment":[{"href":"https:\/\/tlab.com.tr\/en\/wp-json\/wp\/v2\/media?parent=12163"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tlab.com.tr\/en\/wp-json\/wp\/v2\/categories?post=12163"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tlab.com.tr\/en\/wp-json\/wp\/v2\/tags?post=12163"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}